Strain SummaryC3H/HeNCr

Strain Name

 C3H/HeNCr

Strain Type(s)

 inbred

Strain Synonym(s)

 C3H  •  C3H/He  •  C3H/HeNCr MTV-  •  C3H/HeNCrMTV-

Strain Links

 • Festing's List of Inbred Strains

Models

118 unique models displayed. A model is a set of tumors that share the same tumor name, organ(s) affected, and treatment type for a specific strain.
Frequency
Model Name Organ Affected Tumor Inducing Agent(s) Female Male Mixed Pop. Unspecified Additional Information Model Details
Adipose tissue lipoma Kidney

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adipose tissue lipoma Intestine - Small Intestine

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex adenoma Adrenal gland - Cortex

8.3

37.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex adenoma Adrenal gland - Cortex 12-O-tetradecanoylphorbol-13-acetate (TPA)

0

30

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex adenoma Adrenal gland - Cortex sodium arsenite

0 - 4.8

65 - 71

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex adenoma Adrenal gland - Cortex sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

4.5 - 9.5

57 - 65

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex carcinoma Adrenal gland - Cortex

0

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex carcinoma Adrenal gland - Cortex 12-O-tetradecanoylphorbol-13-acetate (TPA)

4.2

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex carcinoma Adrenal gland - Cortex sodium arsenite

0

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Cortex carcinoma Adrenal gland - Cortex sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

0

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Adrenal gland - Medulla pheochromocytoma Adrenal gland - Medulla sodium arsenite

4.8

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Liver

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Uterus

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Ovary

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Leg

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Oviduct

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Heart

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Kidney

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Intestine - Small Intestine

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangioma Spleen

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Blood vessel hemangiosarcoma Liver

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Connective tissue - Fibroblast fibrosarcoma Preputial gland (male)

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Connective tissue myxoma Uterus - Cervix

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Eye - Harderian gland adenoma Eye - Harderian gland

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Eye - Harderian gland carcinoma Eye - Harderian gland

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Kidney lesion Kidney N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

6

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Leukocyte lymphohematopoietic neoplasm Leukocyte N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

32

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Leukocyte lymphoma Leukocyte beta-naphthoflavone (betaNF)

6.3

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Leukocyte lymphoma Leukocyte

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatoblastoma Liver sodium arsenite

4.8

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular adenoma Liver N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)   ⋅   beta-naphthoflavone (betaNF)

6.9

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Liver hepatocellular adenoma Liver

6.7 - 8.3

42

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4   ⋅   Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular adenoma Liver sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

18 - 29

52 - 76

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular adenoma Liver sodium arsenite

13 - 14

52 - 90

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular adenoma Liver 12-O-tetradecanoylphorbol-13-acetate (TPA)

8.3

35

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular carcinoma Liver N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

3.0

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Liver hepatocellular carcinoma Liver sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

9.1 - 19

26 - 33

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular carcinoma Liver sodium arsenite

4.8 - 13

35 - 48

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular carcinoma Liver

4.2

12.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular carcinoma Liver 12-O-tetradecanoylphorbol-13-acetate (TPA)

8.3

8.7

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular tumor Liver sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

27 - 38

65 - 86

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular tumor Liver sodium arsenite

19 - 26

61 - 90

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular tumor Liver 12-O-tetradecanoylphorbol-13-acetate (TPA)

12.5

39

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver hepatocellular tumor Liver

12.5

50

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Liver lesion Liver N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

82

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Liver lesion Liver

66

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Lung adenoma Lung

4.2

17

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung adenoma Lung 12-O-tetradecanoylphorbol-13-acetate (TPA)

4.2

8.7

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung adenoma Lung sodium arsenite

8.7 - 9.5

24 - 26

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung adenoma Lung sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

9.1 - 29

24 - 43

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung carcinoma Lung

0

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung carcinoma Lung 12-O-tetradecanoylphorbol-13-acetate (TPA)

4.2

4.3

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung carcinoma Lung sodium arsenite

0

4.3 - 4.8

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung carcinoma Lung sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

0 - 9.1

0 - 9.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung lesion Lung N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

74

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Lung lesion Lung

7

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Lung tumor Lung N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

79

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Lung tumor Lung N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)   ⋅   beta-naphthoflavone (betaNF)

86

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Lung tumor Lung beta-naphthoflavone (betaNF)

6.3

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Lung tumor Lung

4.2 - 6.7

17

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4   ⋅   Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung tumor Lung 12-O-tetradecanoylphorbol-13-acetate (TPA)

8.3

13

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung tumor Lung sodium arsenite

8.7 - 9.5

29 - 30

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Lung tumor Lung sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

18 - 29

33 - 43

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mammary gland adenocarcinoma Mammary gland

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Melanocyte melanoma Uterus - Cervix

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mesodermal cell/mesoblast sarcoma Skin sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

4.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mesodermal cell/mesoblast sarcoma Skin

8.3

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mesodermal cell/mesoblast sarcoma Leg

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mesodermal cell/mesoblast sarcoma Liver

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mesodermal cell/mesoblast sarcoma Peritoneum

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Mesodermal cell/mesoblast squamous cell sarcoma Forestomach

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Muscle - Smooth leiomyoma Uterus

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Muscle - Smooth leiomyosarcoma Muscle - Smooth N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)   ⋅   beta-naphthoflavone (betaNF)

3.4

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Ovary - Germ cell teratoma Ovary - Germ cell N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)   ⋅   beta-naphthoflavone (betaNF)

3.4

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Ovary adenoma Ovary sodium arsenite

17 - 19

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary adenoma Ovary

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary adenoma Ovary 12-O-tetradecanoylphorbol-13-acetate (TPA)

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary adenoma Ovary sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

19 - 23

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary carcinoma Ovary

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary carcinoma Ovary 12-O-tetradecanoylphorbol-13-acetate (TPA)

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary carcinoma Ovary sodium arsenite

0 - 4.3

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary carcinoma Ovary sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary tumor Ovary N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)   ⋅   beta-naphthoflavone (betaNF)

3.4

References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4

Ovary tumor Ovary

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary tumor Ovary 12-O-tetradecanoylphorbol-13-acetate (TPA)

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary tumor Ovary sodium arsenite

19 - 22

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Ovary tumor Ovary sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

19 - 23

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Oviduct adenoma Oviduct sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

4.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Oviduct hyperplasia Oviduct

12.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Oviduct hyperplasia Oviduct 12-O-tetradecanoylphorbol-13-acetate (TPA)

12.5

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Oviduct hyperplasia Oviduct sodium arsenite

35 - 48

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Oviduct hyperplasia Oviduct sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

32 - 43

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

PNS - Schwann cell schwannoma Nerve N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

5.5

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

PNS - Schwann cell schwannoma Nerve

0

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Pituitary gland lesion Pituitary gland N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

8

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Renal pelvis papilloma Renal pelvis

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Skin squamous cell carcinoma Skin sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

4.3

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Stomach lesion Stomach N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

12

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Thyroid gland adenoma Thyroid gland

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Thyroid gland lesion Thyroid gland N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU)

7

References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9

Ureter transitional cell carcinoma Ureter

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus adenoma Uterus

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus adenoma Uterus 12-O-tetradecanoylphorbol-13-acetate (TPA)

0

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus adenoma Uterus sodium arsenite

4.3 - 4.8

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus adenoma Uterus sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

4.5 - 4.8

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus hyperplasia - cystic Uterus

25

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus hyperplasia - cystic Uterus 12-O-tetradecanoylphorbol-13-acetate (TPA)

29

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus hyperplasia - cystic Uterus sodium arsenite

61 - 67

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus hyperplasia - cystic Uterus sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

68 - 71

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus lesion Uterus

25

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus lesion Uterus 12-O-tetradecanoylphorbol-13-acetate (TPA)

29

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus lesion Uterus sodium arsenite

65 - 71

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

Uterus lesion Uterus sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

73 - 76

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

(Unspecified organ) adenoma (Unspecified organ) sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

(Unspecified organ) tumor (Unspecified organ) 12-O-tetradecanoylphorbol-13-acetate (TPA)

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

(Unspecified organ) tumor (Unspecified organ)

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

(Unspecified organ) tumor (Unspecified organ) sodium arsenite

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41

(Unspecified organ) tumor (Unspecified organ) sodium arsenite   ⋅   12-O-tetradecanoylphorbol-13-acetate (TPA)

observed

observed

References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41